CONFIRMED USE OF ANTIRETROVIRAL DRUGS FOR HIV THERAPY IN TWO BLOOD DONORS WITH POTENTIAL ELITE CONTROLLER PROFILE FROM SÃO PAULO
AS Nishiyaa,b, NA Sallesa, C Almeida-Netoa,c, SCFS Lombardia,b, FAH Nogueiraa, V Rochaa,b,c,d, A Mendrone-Jra,b
a Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, SP, Brazil
b Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Oncoimmunohematology (LIM-31), Department of Hematology, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
c Disciplina de Ciências Médicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
d Churchill Hospital, Oxford University, Oxford, Reino Unido
Read
1097
Timeswas read the article
486
Total PDF
611
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 26 | 18 | 44 |
| 2025 6 | 41 | 16 | 57 |
| 2025 5 | 49 | 14 | 63 |
| 2025 4 | 42 | 14 | 56 |
| 2025 3 | 52 | 11 | 63 |
| 2025 2 | 35 | 18 | 53 |
| 2025 1 | 27 | 20 | 47 |
| 2024 12 | 23 | 8 | 31 |
| 2024 11 | 30 | 17 | 47 |
| 2024 10 | 27 | 11 | 38 |
| 2024 9 | 17 | 19 | 36 |
| 2024 8 | 23 | 28 | 51 |
| 2024 7 | 18 | 28 | 46 |
| 2024 6 | 21 | 21 | 42 |
| 2024 5 | 17 | 23 | 40 |
| 2024 4 | 18 | 14 | 32 |
| 2024 3 | 12 | 14 | 26 |
| 2024 2 | 20 | 27 | 47 |
| 2024 1 | 14 | 14 | 28 |
| 2023 12 | 11 | 12 | 23 |
| 2023 11 | 8 | 15 | 23 |
| 2023 10 | 18 | 29 | 47 |
| 2023 9 | 12 | 18 | 30 |
| 2023 8 | 6 | 11 | 17 |
| 2023 7 | 6 | 3 | 9 |
| 2023 6 | 9 | 12 | 21 |
| 2023 5 | 5 | 3 | 8 |
| 2023 4 | 3 | 5 | 8 |
| 2023 3 | 3 | 8 | 11 |
| 2023 2 | 4 | 8 | 12 |
| 2023 1 | 2 | 5 | 7 |
| 2022 12 | 6 | 12 | 18 |
| 2022 11 | 4 | 7 | 11 |
| 2022 10 | 2 | 3 | 5 |
Show all
